Evidence map›Paper›PMID 29661869›Full record

ArticleAntimicrobial agents and chemotherapy2018

Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.

Yingjun Liu, Henry Pertinez, Geraint R Davies, Stephen H Gillespie, Anthony R Coates, Yanmin Hu

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. One Size Fits All? Not inFrontiers in cellular and infection microbiology · 2021
    Review
  2. Article
  3. Effect of Moxifloxacin plus Pretomanid againstAntimicrobial agents and chemotherapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yingjun LiuInstitute for Infection and immunity, St. George's, University of London, London, United Kingdom.
Henry PertinezDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
Geraint R DaviesDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
Stephen H GillespieSchool of Medicine, University of St. Andrews, St. Andrews, United Kingdom.
Anthony R CoatesInstitute for Infection and immunity, St. George's, University of London, London, United Kingdom.
Yanmin HuInstitute for Infection and immunity, St. George's, University of London, London, United Kingdom ymhu@sgul.ac.uk.
St George's, University of London · GBUniversity of Liverpool · GBUniversity of St Andrews · GB

Funding

Medical Research Council MR/P011144/1
6 · The paper itself

Abstract

Tuberculosis (TB), which is caused by

Indexed as

AnimalsAntitubercular AgentsDisease Models, AnimalDrug Therapy, CombinationEthambutolFemaleIsoniazidMiceMice, Inbred BALB CMice, Inbred C3HMoxifloxacinMycobacterium tuberculosisRecurrenceTuberculosis, PulmonaryAntitubercular AgentsEthambutolIsoniazidMoxifloxacinCornell mouse modelmoxifloxacinMycobacterium tuberculosisresuscitation-promoting factors

Identifiers

PMID29661869
PMCPMC6021622
OpenAlexW2796617452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.